July 24, 2014 11:10 PM ET

Biotechnology

Company Overview of Abmaxis, Inc.

Company Overview

Abmaxis, Inc., a biopharmaceutical company, engages in the discovery, optimization, and development of monoclonal antibody (MAb) products for human therapeutics and diagnostics. It offers Abmaxis in-silico Immunization (AISIM), an antibody engineering technology platform, which is used for building an internal product pipeline and for collaborations with global biotech and pharmaceutical partners. The company was incorporated in 2000 and is based in Santa Clara, California. As of May 9, 2006, Abmaxis, Inc. operates as a subsidiary of Merck & Co., Inc.

3303 Octavius Drive

Suite 103

Santa Clara, CA 95054

United States

Founded in 2000

Phone:

408-988-6100

Key Executives for Abmaxis, Inc.

Chief Executive Officer and President
Age: 76
Co-Founder and Chief Technology Officer
Co-founder and Vice President of Product Development
Co-founder and Vice President of Molecular Biology
Vice President of Business Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Global Grain Security, LLC United States
EQALIX Inc United States
Exagen Diagnostics, Inc. United States
Intelligent Medical Devices, Inc. United States
ProSci Incorporated United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Abmaxis, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.